Anthem’s Obamacare exit could leave 300,000 without options
The loss of another insurer in the program would put more pressure on Republicans in Congress who are attempting to repeal and replace large parts of Obamacare.
The loss of another insurer in the program would put more pressure on Republicans in Congress who are attempting to repeal and replace large parts of Obamacare.
One of the nation’s biggest health insurers says it will not return to Ohio’s public insurance exchanges next year, a decision that could open more holes in the Affordable Care Act’s increasingly thin system for helping people buy coverage.
Planned Parenthood of Indiana and Kentucky Inc. on Tuesday announced the hiring of a veteran not-for-profit leader to replace Betty Cockrum, who is retiring after 15 years as president and CEO of the organization.
A set of consolidated lawsuits accuse AbbVie and other makers of testosterone-replacement medicines, including Eli Lilly and Co., of hiding or downplaying their products’ risk for blood clots or other serious injuries.
Religious hospitals don't have to comply with federal laws protecting pension plans, a unanimous Supreme Court ruled Monday in a case that affects retirement benefits for roughly a million workers.
The first case against Bloomington-based Cook Group from patients who say the company’s blood-clot filters malfunctioned is headed for trial this fall in Indianapolis.
Prosecutors argue that subpoenas issued by counsel for the nursing home company's former CEO are overly broad and "an abuse of process."
Most of the cuts this summer will come from the hospital system’s billing operations in Indianapolis.
Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
Top pharmaceutical CEOs say they expect President Donald Trump, a frequent critic of industry pricing practices, to take steps soon to address high U.S. drug costs.
For the first time since its founding in 1996, the Women’s Fund of Central Indiana is supporting an initiative that’s not exclusive to females.
The state is asking vendors to submit bid packages by June 12 for a drug whose price has spiked in recent years.
Indiana ranks 44th nationwide in the capacity to meet the medication-assisted treatment needs of our population.
Indiana’s Management Performance Hub is organizing and analyzing data to help state agencies make better decisions about fighting the opioid scourge and other systemic problems.
LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.
It’s tough to look at your own community and figure out what it’s doing that no one else is. But IBJ gave it a shot. Here are four things other cities could copy from us.
People shopping for insurance through the Affordable Care Act in yet more regions could be facing higher prices and fewer choices next year. A new report shows Affordable Care Act premiums have soared since 2013.
Indiana Gov. Eric Holcomb asked the Centers for Medicare and Medicaid Services on Wednesday for permission to impose such a requirement.
The bill to repeal and partially replace Obamacare would reduce the deficit by $119 billion over 10 years, the Congressional Budget Office said.
Roche Group is rolling out a new blood-glucose meter and a savings program for test strips, which it says it will make diabetes care more affordable.